missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18118125

LZIC Antibody (OTI2D4), Alexa Fluor™ 488, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-72560AF488

Product Code. 18118125

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LZIC Monoclonal specifically detects LZIC in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LZIC
Monoclonal
Alexa Fluor 488
50mM Sodium Borate with 0.05% Sodium Azide
LZIC
Full length recombinant protein of human LZIC (NP_115744) produced in HEK293T cells.
0.1 mL
Primary
Human, Mouse, Rat
IgG1
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI2D4
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
leucine zipper and CTNNBIP1 domain containing, Leucine zipper and CTNNBIP1 domain-containing protein, Leucine zipper and ICAT homologous domain-containing protein, leucine zipper domain and ICAT homologous domain containing, MGC15436, protein LZIC
Mouse
Affinity Purified
Neuroscience
84328.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.